Aberrant phospholipid and sphingolipid metabolism is a primary and targetable pathology in Alzheimer Disease

Project Number
EUJPND-CIHR-Multiple PI-425
Agency/Funding Organization
Canadian Institutes of Health Research (CIHR)
Funding Year
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Multiple PI
Principal Investigator Last Name
Multiple PI
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
Funding Organization